Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL9 | O00512 | 1/20 | 0.60 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 9/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | LMNA | P02545 | 3/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | HTT | P42858 | 1/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.46 |
| ▸ | ESR1 | P03372 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27429774 | 0.98 | BCL9 (0.58) | BCL9CTNNB1KMT2AALDH1A1LMNA | |
| SCHEMBL11023644 | 0.90 | BCL9 (0.70) | BCL9CTNNB1KMT2AALDH1A1LMNA | |
| SCHEMBL224788 | 0.89 | KMT2A (0.52) | BCL9CTNNB1KMT2AALDH1A1LMNA | |
| SCHEMBL10652449 | 0.88 | KMT2A (0.63) | BCL9CTNNB1KMT2AALDH1A1LMNA | |
| SCHEMBL11513733 | 0.87 | KMT2A (0.57) | BCL9CTNNB1KMT2AALDH1A1LMNA | |
| SCHEMBL11650732 | 0.86 | KMT2A (0.59) | BCL9CTNNB1KMT2AALDH1A1LMNA | |
| SCHEMBL299704 | 0.86 | KMT2A (0.59) | BCL9CTNNB1KMT2AALDH1A1LMNA | |
| SCHEMBL27709110 | 0.86 | KMT2A (0.59) | BCL9CTNNB1KMT2AALDH1A1LMNA | |
| SCHEMBL16586533 | 0.86 | KMT2A (0.59) | BCL9CTNNB1KMT2AALDH1A1LMNA | |
| SCHEMBL6836918 | 0.84 | BCL9 (0.64) | BCL9CTNNB1KMT2AALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 508 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118851722-B | Carbon mineralized plate and preparation method thereof | 苏州同萃碳中和科技有限公司 | 2025-01-24 | — | — | CN | claimed |
| CN-118851722-A | Carbon mineralized plate and preparation method thereof | 苏州同萃碳中和科技有限公司 | 2024-10-29 | — | — | CN | claimed |
| CN-118056598-A | Preparation method of pervaporation membrane, application of pervaporation membrane in hydrogen chloride gas refining and refining method of pervaporation membrane | 万华化学集团股份有限公司 | 2024-05-21 | — | — | CN | claimed |
| WO-2023238126-A1 | COMPOSITION AND METHOD FOR USE THEREOF FOR TREATMENT AND PREVENTION OF AUTOIMMUNE AND NEUROLOGICAL DISORDERS | LEVICURE LTD (IL) | 2023-12-14 | — | — | WO | claimed |
| CN-110256298-A | 4,4 '-dinitro phenylurea haptens and artificial antigen and the preparation method and application thereof | 中国农业大学 | 2019-09-20 | — | — | CN | claimed |
| CN-110003101-A | A kind of Ah pa is for Buddhist nun's intermediate and preparation method thereof | 苏州富士莱医药股份有限公司 | 2019-07-12 | — | — | CN | claimed |
| CN-106905175-B | A kind of preparation method of p-aminophenyl butyric acid | 厦门市瑞思医药科技有限公司 | 2019-06-04 | — | — | CN | claimed |
| CN-106905175-A | A kind of preparation method of p-aminophenyl butyric acid | 厦门市瑞思医药科技有限公司 | 2017-06-30 | — | — | CN | claimed |
| CN-106456662-A | Compositions of pentosan polysulfate for oral administration and methods of use thereof | 奥利金制药公司 | 2017-02-22 | — | — | CN | claimed |
| CN-103495340-B | The method of SOx in compound alcamines solution removal gas | BEIJING BOYUAN HENGSHENG HIGH-TECHNOLOGY CO.,LTD. (CN) | 2015-11-18 | — | — | CN | claimed |
| US-20040197408-A1 | micelle-forming biocompatible diblock copolymer (X Y) having a hydrophilic block X, and a hydrophobic block Y, an amino acid and a hydrophobic drug (paclitaxel ); form micelles at an enhanced rate, have an enhanced ability to incorporate drugs | ANGIOTECH INTERNATIONAL AG (CH) | 2004-10-07 | — | — | US | claimed |
| US-5962710-A | Method of preparing salicyloylamino acids | EMISPHERE TECHNOLOGIES, INC. (US) | 1999-10-05 | — | — | US | claimed |
| EP-0883629-A1 | OLIGOPEPTIDES FOR DRUG DELIVERY | Emisphere Technologies, Inc. (US) | 1998-12-16 | — | — | EP | claimed |
| WO-1998050341-A1 | METHOD OF PREPARING SALICYLOYLAMINO ACIDS | EMISPHERE TECHNOLOGIES, INC. (US) | 1998-11-12 | — | — | WO | claimed |
| CN-1039126-C | Tachiquinine antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds | MENARINI FARMA IND (IT) | 1998-07-15 | — | — | CN | claimed |
| CN-1183786-A | Bicyclic tachykinins antagonists, preparation thereof and their use in autagonistes composition | MENARINI FARMA IND (IT) | 1998-06-03 | — | — | CN | claimed |
| WO-1997031938-A9 | OLIGOPEPTIDES FOR DRUG DELIVERY | — | 1997-11-20 | — | — | WO | claimed |
| CN-1161962-A | Sulphonic-acid-amide derivative | KONO PHARMACEUTICAL IND K K (JP) | 1997-10-15 | — | — | CN | claimed |
| WO-1997031938-A1 | OLIGOPEPTIDES FOR DRUG DELIVERY | EMISPHERE TECHNOLOGIES, INC. (US) | 1997-09-04 | — | — | WO | claimed |
| CN-1080916-A | The quinic tricyclic compound of anti-column foot, its preparation method and contain the pharmaceutical composition of this compound | MENARINI FARMA IND (IT) | 1994-01-19 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040197408-A1 | micelle-forming biocompatible diblock copolymer (X Y) having a hydrophilic block X, and a hydrophobic block Y, an amino acid and a hydrophobic drug (paclitaxel ); form micelles at an enhanced rate, have an enhanced ability to incorporate drugs | MLX, BMX, MTX1 | BCL9 1992/4885CTNNB1 3340/4885KMT2A 3338/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.